type full_text Discharge Summary HOSPITAL INPATIENT DISCHARGE SUMMARY HOSPITAL COPY [REDACTED] [REDACTED][REDACTED] | [REDACTED_PASSPORT] | 83 years | Female | Chinese | [REDACTED_VISIT_NO] ADMISSION DETAILS Admission Date: 14/9/2021 [REDACTED_DOB] Admission Time: 19:03 Age: 83 yrs (as of admission) Ward: WARD B 06 S Bed: JW 06 SB 34 Patient Type: Inpatient Patient Class: Class C class Attending Dr [REDACTED] [REDACTED] [REDACTED][REDACTED] Medical Service Code: NTFGH RENAL MEDICINE DISCHARGE DETAILS Discharge Date: 30/9/2021 3:30 PM Discharge Status: Patient discharged [101] Condition at Discharge: Condition better than at time of admission DIAGNOSIS Principal Problem: Pneumonia Active Problems: Fever Resolved Problems: * No resolved hospital problems. * Past Medical History: Diagnosis Date Type 2 diabetes mellitus 2014 Original CPSS 2 Diagnosis converted and mapped by IMO Concepts: DIABETES MELLITUS (DM) TYPE II (NIDDM) (ICD 9 CM, [REDACTED_NUMBER]), Sensitive Diagnosis: No, Updated Date: 16/06/2017, Remark: Converted to [TYPE 2 DIABETES MELLITUS] [197761014] on 16/06/2017 08:57:57, Institution: NHGP, Entered By: [REDACTED] [REDACTED][REDACTED] ([REDACTED_ID 2]), Specialty: Family Med, Updated By: [REDACTED] [REDACTED] [REDACTED][REDACTED] ([REDACTED_ID 2]) CLINICAL SUMMARY [REDACTED] [REDACTED][REDACTED] xxxxx 652 H 83 y.o. Allergies Allergen Reactions Enalapril Fenofibrate Nifedipine ADLs: ADL dependent, /chair/bed bound Main caregiver: helper Stays with helper and grandson Past Medical History 1. HTN, HLD 2. AF (CHADsVASc 7 HASBLED 3) Previously on rivaroxaban Admitted in Aug 2021 for left UL haematoma and PR bleeding Discussed with family: Not for NOAC keen for warfarin despite explaining frequent INR checks and clinic visits risks of bleeding (GI/GU/ICH/MSK) to rediscuss in GRM TCU 3. Severe TR with recurrent admission for fluid overload TTE 12/3/21: LVEF 55 . Dilated TV annulus (38 mm) with moderate to severe TR. Severe bi atria dilatation. Aortic valve sclerosis. Moderate degenerative and calcified mitral stenosis. Mild to moderate MR [REDACTED] [REDACTED] [REDACTED][REDACTED]: Negative for ischemia Previously on Frusemide > switched to Bumetanide during admission in June 2021 Dry weight 56 kg F/u CGH CVM but transferred care to NTF ivo relocation 4. Previous CVA CT Brain 2020: Mild chronic microvascular ischaemia and age appropriate generalised cerebral involution. Stable gliosis involving the right thalamus/right internal capsule posterior limb. 5. CKD (B/l Cr 100 120) Baseline Cr 100 120 6. NCNC Fe anaemia b/g H pylori Gastritis. Baseline Hb 10 12 OGD/colono done in April 2014: H pylori gastritis, colono NAD s/p triple therapy 7. Cholestatic LFT likely hepatic congestion 8. L UL weakness since birth 9. Right Lower limb ulcers likely 2' chronic lower limb oedema, PAD 11. History of E. coli sepsis secondary to right pyelonephritis in 2012 13. Gout UA 713 April 2021 14. Bilateral Knee OA, pes planus 15. Right cataract s/p Right Phaco/IOL 16. Osteoporosis Previously on denosumab, then discussed at GRM clinic to hold off ivo limited time to benefit 17. Cognitive decline since 2021 due to repeated hospitalisations Cx by delirium, worsening behavioural issues (sleep wake reversal) over 2 months Probably underlyin mixed dementia AMT 7/10, MMSE 19/29 (Orientation 5, attention 1, delayed recall 3, language 7, construction 0) Jul 2021 no previous education < MMSE 22/30 in Oct 2020 18. Coagulopathy secondary to NOAC complicated by left UL hematoma PR bleeding , with Hb drop (AUG 21) referred to Haematology: hold off PCC for now as Hb is stable inpatient, and in view of elevated risk of stroke. However, if there is worsening neurovascular status of UL, limb or life threatening considerations, to consider PCC > did not require PCC this admission referred to ortho: no intervention from ortho point of view. No drainable collection Last Admission Just discharged 7/9/2021 1. ADHF Precipitated by UTI B/g AF, Severe TR, b/g on Bumetanide 1 mg BD TTE 12/3/21: LVEF 55 . Dilated TV annulus (38 mm) with moderate to severe TR. Severe bi atria dilatation. Aortic valve sclerosis. Moderate degenerative and calcified mitral stenosis. Mild to moderate MR PR. TW 6.6 CRP 15.3 CXR Overloaded with bilateral pleural effusion UFEME Nitrite ve, 621/378/ Urine cs Klebsiella Pneumoniae, lt s gt Cephalexin, Gentamicin, Bactrim, Augmentin lt r gt Ampicillin/Amoxicillin started on IV Ceftriaxone for treatment of UTI increased to Bumetanide 2 mg BD and added Metalazone 2.5 mg OM had borderline hypotension diuretics reduced to bumetamide 1 mg BD Cx by Trop Leak Trop 74>72.6 (from 48 10 Aug) ECG no ST T changes 2. Isolated Hyperbilirubinaemia Bil 38 (from 21.2 11 Aug) Rest of LFTs NAD 3. Subclinical Hypothyroidism possibly 2' sick euthyroid possibly attributed to ongoing sepsis TSH 8.17(H) fT4 12.6 tT 3 0.7(L) Chronic Medications No current medication administered on site on file prior to encounter. Current Outpatient Medication on File Prior to Encounter Medication Instructions Dispense Refill Aqueous Cream (100 g) Apply 1 application to affected area 2 times a day for 28 days. Atorvastatin Tablet Take 20 mg every night for 28 days. bisOPROLOl Fumarate Tablet Take 2.5 mg every morning for 28 days. Colecalciferol 1,000 unit Tablet Take 1,000 UNIT every morning for 28 days. ENSURE PLUS (Vanilla) Liquid Take 200 mL 2 times a day for 28 days. iron hydroxide polymaltose tablet 100 MG Take 100 mg every morning with meal for 28 days. Ketoprofen 30 mg Plaster Apply 1 plaster to affected area 2 times a day when required for pain and inflammation for up to 28 days. Lactulose Syrup Take 10 mL 3 times a day for 28 days. Omeprazole 20 mg Capsule Take 20 mg every morning before meal for 28 days. Quetiapine Tablet Take 6.25 mg every night when required (agitation) for up to 28 days. Senna 7.5 mg Tablet Take 2 tablets every night for 28 days. Bumetanide 1 mg Tablet Take 1 mg 2 times a day at 8 am and 4 pm for 28 days. HOPC ED hx from paramedics Patient is standby for fever with low BP. Patient is noted by daughter [REDACTED] to have bilateral UL pain with fever. No cough. No falls or HI. No COVID 19 contact. SBP 85 on scene Patient drowsy unable to obtain history from patient OE Vital Signs Vital signs: 14/09/21 21:01 14/09/21 21:25 14/09/21 22:01 14/09/21 23:01 BP: (S) ( ) 69/44 ( ) 84/51 ( ) 79/49 ( ) 82/54 Pulse: 104 114 105 101 Resp: 25 16 16 21 Temp: SpO2: 100 100 99 100 RA > NP 2 L Results from last 7 days Lab Units 14/09/21 19:12 GLUCOSE (POCT) mmol/L 8.7 On examination: GCS E 3 V 2 M 4 HS 1 S 2 Lungs reduced a/e bibasal ASNT Calves supple, bilateral pedal edema DRE by ED: brown stools, no guarding/ rigidity Investigations Results from last 7 days Lab Units 14/09/21 19:06 WBC X 10Ë9/L 10.00 HAEMOGLOBIN g/dL 9.5* HAEMATOCRIT 30.8* PLATELETS x 10Ë9/L 230 Results from last 1 year Lab Units 02/06/21 21:26 10/08/21 14:21 26/08/21 21:57 03/09/21 11:53 04/09/21 05:07 14/09/21 19:06 SODIUM, SERUM mmol/L 140 141 144 131* 132* 137 POTASSIUM, SERUM mmol/L 4.3 4.2 5.5* 4.4 4.3 4.4 CHLORIDE, SERUM mmol/L 106 99* 103 85* 85* 94* BICARBONATE, SERUM mmol/L 22* 28 25 33* 32* 28 UREA, SERUM mmol/L 12.8* 14.4* 19.6* 18.6* 19.7* 25.8* CREATININE, SERUM umol/L 123* 121* 147* 101* 109* 147* GLUCOSE, SERUM, RANDOM mmol/L 8.6 7.7 6.6 EGFRCKDEPI mL/min/1.73 m 2 35* 36* 28* 44* 41* 28* ANION GAP mmol/L 16.3* 18.2* 21.5* 17.4* 19.3* 19.4* Urine dipstick: leu 3 , nit neg, prot 2 , blood 3 ECG: AF, rate 110, no acute ischemic changes CXR: cardiomegaly, bilateral LZ hazziness, blunted bilateral CPA COVID PCR pending Progress at ED BP dropping given IV HM 250 250 ml IV Tazosin 4.5 g Issues Progress 1) Fever cover for HAI / HAP (resolved) Presented with fever and hypotension Recent hospitalisation for UTI (last urine culture 27/8: Klebsiella Pneumoniae lt s gt Augmentin) TW 8> 5.44 CRP 91> 78.6> 57> 41 UFEME nitrite ve, WBC 67 rbc 7, epithelial ve, bacteria 1 , Urine culture 15/9: NBG CXR: small left pleural effusion and increased density/ground glass. Alveolar consolidation in the left lower lobe. Pulmonary venous congestion is present with signs of fluid overload. Started IV Piptazo 14/09 20/9/21 Complicated by A) Fluid responsive hypotension (resolved) 4 x 250 mL fluid bolus given in ED B) Elevated trops Trops 16/9: 139.9 ( < 151.9 < 210.4) ECG: AF, rate 115, no acute ischemic changes 2) Oligouria 2' worsening AoCKD, 2' cardiorenal syndrome from underlying CCF B/g progressive CKD , presumed hypertensive nephrosclerosis , with recurrent recent AKIs Baseline Cr 110, OA Cr 147 Cr 147 > 190 > 233 > 273 (20/9/21) > 319 > 377 > 418 IDC last changed on 15/9/21 US KUB 20/9/21: No obstruction or structural abnormality Referred to RENAL: AKI likely secondary to cardiorenal syndrome > Suggest to continue with diuresis 23/9: R Comm Fem Vein inserted, net UF 0 ml due to Hypotension 24/9: UF 1000 ml cx A. T 2 RF with difficulty weaning off NIV ABG 23/09: 7.23, pCO 2 52, pO 2 152 BiCarb 21.6 started on BiPAP on 23/09 for respi support and subsequent difficulty weaning off Noted bilateral pleural effusion (L>R) on bedside US ICM advised for L chest drain insertion s/p IR guided L chest drain insertion on 25/09 aspirated 300 mls, nil complications during procedure noted Pleural studies: > pH 7.6, Protein 30, LDH 114 (serum Protein 69, LDH 272) > Fluid cell count: slightly blood stained: RBC 6000, Nucleated cells 218 > Largely lymphocytic (57 lymphocytes, 9 Neutrophils) > Gram stain: 2 WBC, Nil organisms seen > TB PCR: nil seen 3) Oral thrush White patches on tongue, attempts at scraping to remove patches unsuccsessful, no tongue pain Started Nystatin on 18/09 4) Hypotension likely multifactorial DDx: NSTEMI, Pleural effusion, Dehydration Trops 500 > 447 ECG: AF, ?TWI in VIII Decision made on 28/09 that pt is not safe for dialysis ivo low BP family understood B/g NCNC anaemia Baseline Hb 10 s, Hb OA 9.5 OGD/colono done in April 2014: H pylori gastritis, colono NAD iron 8.2, ferritin 300, vit B 12/folate replete B/g AF with Severe TR Previously on rivaroxaban > not on NOAC now ivo recent admission in Aug 2021 for left UL haematoma and PR bleeding TTE 12/3/21: LVEF 55 . Dilated TV annulus (38 mm) with moderate to severe TR. Severe bi atria dilatation. Aortic valve sclerosis. Moderate degenerative and calcified mitral stenosis. Mild to moderate MR PR. Referred to and assessed by palliative team on 28/9/21: Mdm [REDACTED] [REDACTED] [REDACTED][REDACTED] year old chinese female with b/g Afib, HTN, HLD, severe TR with EF 55 (Mar 2021), CKD, likely mixed dementia, complicated by recurrent admissions for fluid overload. 1. Worsening oliguric AoCKD 2' cardiorenal syndrome due to CCF, unable to tolerate trial of dialysis this admission due to intradialytic hypotension Medical decision made not for further hemodialysis on 28/09/21 Prognosis is guarded for patient given overall clinical picture 2. Left pleural effusion (pleural fluid analysis transudative in nature) s/p left chest tube drainage D 4 3. Global decline from progressive AoCKD (latest 32.6, Cr 523 on 27/9/21) 4. Patient clinically not in respiratory distress. Other symptoms include hypoactive delirium possibly contributed by uremia, recurrent episodes of desaturation and hypotension 5. Noted family is keen to support patient for terminal care at home Prognosis is short days, and will require home hospice support This patient was terminally discharge on 30/09/2021 CCOD: Pneumonia B/g AKI DISCHARGE PLAN